{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:23:04Z","timestamp":1771626184163,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0002-9394(02)01643-4","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T15:23:56Z","timestamp":1034004236000},"page":"552-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma"],"prefix":"10.1016","volume":"134","author":[{"given":"William E","family":"Sponsel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmarco","family":"Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(02)01643-4_BIB1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/08820539909061464","article-title":"Prostaglandin analogues in the treatment of glaucoma","volume":"14","author":"Hejkal","year":"1999","journal-title":"Sem Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/13543784.10.4.679","article-title":"Therapeutic potential of prostaglandin analogues in glaucoma","volume":"10","author":"Linden","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0039-6257(97)80002-1","article-title":"Prostaglandins","volume":"41","author":"Bito","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB4","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0039-6257(97)80020-3","article-title":"The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color","volume":"41","author":"Wistrand","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(93)31484-3","article-title":"Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes","volume":"100","author":"Toris","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002512-199609050-00007","article-title":"Latanoprost\u2014a review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension","volume":"9","author":"Patel","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/108076801750125612","article-title":"Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma","volume":"17","author":"Tamada","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.84.6.579","article-title":"A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension","volume":"84","author":"O\u2019Donaghue","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-5155(97)00128-7","article-title":"A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes","volume":"42","author":"Serle","year":"1998","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0161-6420(00)00495-4","article-title":"A double-masked, randomized trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension","volume":"108","author":"Susannah","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9394(00)00943-0","article-title":"A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension","volume":"131","author":"Aung","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00061198-200112000-00009","article-title":"A comparison of intraocular pressure-lowering effect of prostaglandin F2-alpha analogues, latanoprost, and unoprostone isopropyl","volume":"10","author":"Kobayashi","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2165\/00002018-199920060-00004","article-title":"A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension","volume":"20","author":"Eisenberg","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9394(01)01096-0","article-title":"Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma","volume":"132","author":"Saito","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9394(00)00824-2","article-title":"Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%","volume":"131","author":"Stewart","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0002-9394(01)01101-1","article-title":"Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%","volume":"132","author":"Alward","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0002-9394(01)01083-2","article-title":"Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%","volume":"132","author":"Eisenberg","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9394(01)01286-7","article-title":"Latanoprost and brimonidine","volume":"133","author":"Sponsel","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(00)00401-3","article-title":"Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye","volume":"130","author":"Sponsel","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jop.1993.9.373","article-title":"Topical ophthalmic beta blockers","volume":"9","author":"Zimmerman","year":"1993","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB21","first-page":"2214","article-title":"Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro","volume":"38","author":"Lindsey","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0021-5198(19)30809-1","article-title":"Metabolites of isopropyl unoprostone as potential ophthalmic solutions reduce intraocular pressure in pigmented rabbits","volume":"81","author":"Kashiwagi","year":"1999","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bjo.75.2.71","article-title":"Postural studies in pulsatile ocular blood flow","volume":"75","author":"Trew","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bjo.82.7.731","article-title":"Pulsatile ocular blood flow investigation in asymmetric normal tension glaucoma and normal subjects","volume":"82","author":"Fontana","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-2008-1050042","article-title":"Oculo-oscillodynamography findings in glaucoma without hypertension","volume":"195","author":"Hofmann","year":"1989","journal-title":"Kin Monatsbl Augenheilkd"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bjo.75.8.466","article-title":"Pulsatile ocular blood flow in patients with low tension glaucoma","volume":"75","author":"James","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB27","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJM200006013422218","article-title":"Sildenafil and ocular perfusion","volume":"342","author":"Sponsel","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1350-9462(00)00003-3","article-title":"Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment","volume":"19","author":"Stjernschantz","year":"2000","journal-title":"Prog Ret Eye Res"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archopht.117.10.1363","article-title":"Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye","volume":"117","author":"Stjernschantz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000027454","article-title":"Effects of 0.005% latanoprost on optic nerve head and peripapillary retinal blood flow","volume":"213","author":"Seong","year":"1999","journal-title":"Ophthalmologica"},{"issue":"Suppl","key":"10.1016\/S0002-9394(02)01643-4_BIB31","first-page":"40","article-title":"Latanoprost 0.005% in POAG","volume":"227","author":"Vertugno","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/eye.1999.6","article-title":"The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma","volume":"13","author":"McKibben","year":"1999","journal-title":"Eye"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9394(00)00797-2","article-title":"Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes","volume":"131","author":"Geyer","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0021-5155(99)00215-4","article-title":"Effects of isopropyl unoprostone on rabbit ciliary artery","volume":"44","author":"Hayashi","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0021-5155(01)00454-3","article-title":"Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus","volume":"46","author":"Makimoto","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB36","first-page":"1499","article-title":"Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles","volume":"42","author":"Yu","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/10807680152729202","article-title":"Effect of topical unoprostone on circulation of human optic nerve head and retina","volume":"17","author":"Tamaki","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/S0002-9394(02)01643-4_BIB38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004170000233","article-title":"An evaluation of the effect of unoprostone isopropyl 0.15% on ocular hemodynamics in normal-tension glaucoma patients","volume":"239","author":"Beano","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402016434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402016434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:30:13Z","timestamp":1757593813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402016434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0002939402016434"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(02)01643-4","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(02)01643-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}